Bullous pemphigoid / pemphigoid

• (2022): Husein-ElAhmed H+, J Dermatolog Treat Jun, Online ahead of print (15 cases) [REVIEW] (Naranjo Adverse Drug Reaction Probability Scale)

Leukocytoclastic vasculitis (angiitis)

• (2022): da Silva Cendon Duran C+, Arch Rheumatol 37(2), 300-310 [REVIEW]

Psoriasis

• (2020): Afach S+, Br J Dermatol May, Online ahead of print [REVIEW]
• (2020): Montolio Chiva L+, Reumatol Clin Mar, Epub ahead of print [REVIEW]

Vasculitis (angiitis) / cutaneous vasculitis (angiitis)

• (2016): Gutierrez-Gonzalez LA, Curr Rheumatol Rep 18(7), 39 [REVIEW]

Hepatotoxicity / liver injury / acute liver injury / drug-induced liver injury (DILI)

• (2021): Jee A+, Int J Mol Sci 22(6), 2954 [REVIEW]

Infusion-related reactions

• (2016): Al-Mayouf SM+, Int J Rheum Dis 19(6), 60034%

Uveitis / anterior uveitis / posterior uveitis / panuveitis

• (2020): Klein A+, ACR Open Rheumatol 2(1), 376%

Adverse effects / adverse reactions

• (2023): Herndon TM+, PLoS One 18(10), e0292231 [REVIEW]
• (2020): Iannone LF+, PLoS One 15(11) (e-Collection)
• (2020): Roberti R+, Curr Med Res Opin Jun, Online ahead of print
• (2016): Al-Mayouf SM+, Int J Rheum Dis 19(6), 60035%

Adverse pregnancy outcomes

• Negative findings
• (2025): Li S+, Autoimmun Rev May, Online ahead of print [REVIEW]

Infection

• (2020): Klein A+, ACR Open Rheumatol 2(1), 373%